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Abstract
Background: Rickettsia typhi (R. mooseri) is the causative agent of murine typhus. It is one of the most widely
distributed flea-borne diseases with a relatively mild febrile initial illness with six to 14 days of incubation period.
The bacterium is gram negative and an obligate intracellular pathogen. The disease is transmitted to humans and
vertebrate host through fleabites or via contact with infected feces. This paper develops dose-response models of
different routes of exposure for typhus in rodents.
Methods: Data from published articles were analyzed using parametric dose-response relationship models. Dose-
response relationships were fit to data using the method of maximum likelihood estimation (MLE).
Results: Dose-response models quantifying the effects of different ages of rats and time post inoculation in BALB/c
mice were analyzed in the study. Both the adult rats (inoculated intradermally) and newborn rats (inoculated
subcutaneously) were best fit by exponential models and both distributions could be described by a single dose-
response relationship. The BALB/C mice inoculated subcutaneously were best fit by Beta-Poisson models. The time
post inoculation analysis showed that there was a definite time and response relationship existed in this case.
Conclusions: Intradermally or subcutaneously inoculated rats (adult and newborn) models suggest that less than 1
plaque-forming unit (PFU) (1.33 to 0.38 in 95% confidence limits) of the pathogen is enough to seroconvert 50% of
the exposed population on average. For the BALB/c mouse time post inoculation model, an average dose of 0.28
plaque-forming units (PFU) (0.75 to 0.11 in 95% confidence limits) will seroconvert 50% of the exposed mice.
Background
Murine typhus, also known as endemic typhus, is one of
the most widely distributed flea borne diseases. The cau-
sative agent of murine typhus is Rickettsia typhi,p r e -
viously known as R. mooseri. It is a relatively mild
febrile illness with 6 to 14 days of incubation period
[1-3]. It is considered less pathogenic than R. rickettsii
and R. prowazekii (in terms of mortality rate), but R.
typhi is virulent enough to cause severe infection in the
elderly population [3]. The major reservoir of the patho-
gens is the rat (Rattus rattus and R. norvegicus) with the
rat flea (Xenopsylla cheopis) as the main vector. Fleas
are infected by transovarian transmission or acquire the
contagion while feeding on an infected animal [4]. R.
typhi is transmitted to the human body or vertebrate
host by infected fleabites, or contamination of the bro-
ken skin, respiratory tract or conjunctivae of the host
with infected feces or tissues during and after flea feed-
ing [2,3].
The flea once acquiring the infection remains infective
for life. Interestingly, neith e rf l e an o rr a ti sh a r m e db y
the pathogens [2]. Although humans are infected mainly
via rat fleas, murine typhus exists endemically in many
places where rat and rat fleas are absent [3]. In the Uni-
ted States, the reported cases of murine typhus are
focused in south and central Texas, Los Angeles and
Orange County, California, where rats and rat fleas are
rarely documented. The cat flea/opossum cycle may be
one of the possibilities responsible for the disease[5].
The clinical symptoms of infection with R. typhi in
humans are fever, headache, and myalgia. The fever
lasts about 12 days in adults with temperature ranges
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cause meningoencephalitis, interstitial pneumonia and
disseminated vascular lesions [7].
Many researchers have reported the response of ani-
mals to different doses of Rickettsia typhi in order to
develop effective therapy and to study the pathology of
infected animals. The purpose of this study is to develop
dose-response models and to compare the responses in
term of age, route of infection and time post
inoculation.
Methods
Since there have been no previously reported dose-
response relations, the aim of this study was to extract
usable data from the literature and develop dose-
response curves. Criteria for data used in our analysis
are described as:
￿ Route of exposure is explicitly stated (such as inhala-
tion, subcutaneous, intradermal, intravenous etc.)
￿ Methods for dose estimation are described clearly
￿ The number of subjects for each dose group is sta-
ted explicitly
￿ The number of positive responses for each exposure
route is explicitly stated
￿ T h ec r i t e r i au s e dt od e f i n eap o s i t i v ee n d p o i n ta r e
stated
￿ Pathogen is described in detail (source, strain)
￿ The mode of preparation of pathogenic organisms is
described
Aringo-Jaramillo et al. (1984) carried out an experi-
ment with R. typhi i n f e c t i o ni na d u l ta n dn e w b o r n
laboratory rats. Nine different doses of R. typhi were
transdermally and subcutaneously inoculated with sero-
conversion and death as the responses defined as end-
points [8]. Animals with an indirect fluorescent antibody
titer of greater than or equal to 1:40 were considered to
be seroconverted [9,10]. However, no animals died.
Crist et al. (1984) experimented with R. typhi infection
in normal and immune mice. Female BALB/c mice were
subcutaneously inoculated with various doses of R. typhi
and seroconversions on different days (after inoculation)
were observed [10].
Aringo-Jaramillo et al. (1988) conducted experimental
inoculation of R. typhi in young rats of different age
groups. Five different doses were inoculated orally in 3-
day, 7 day and 30 day old rats and seroconversion was
recorded as the endpoint of response [9].
Analysis Method
Dose-response analysis
Dose response relationships were fit to data using the
method of maximum likelihood estimation (MLE) as
described in Haas et al. (1999). All the data sets are
shown in Table 1.
The statistical programming language, “R” http://www.
r-project.org was used for this computation. Two dose
response models (exponential and Beta-Poisson) were
used [11]. Exponential and Beta-Poisson MLE estimates
were made using the BFGS algorithm. Confidence inter-
vals to the best-fit models were determined via boot-
strapping with 10,000 bootstrap iterations.
The exponential dose-response model is given in
equation (1)
P(d) =1− e−kd (1)
where P( d )is the probability of response at dose d
and k is the probability that a single organism can sur-
vive and initiate infection.
The Beta-Poisson model is given by equation (2)
P(d) =1−
 
1+
 
d
N50
 
·
 
2
1/α − 1
  −α
(2)
where N50 is the median infective dose and a is the
slope parameter for the Beta-Poisson model. The equa-
tion (2) is derived from the exact Beta-Poisson equation
with certain assumptions [11,12].
Goodness of fit for all models was determined by
comparing the value of the optimized deviance to the
critical c
2 value at degrees of freedom equal to the
number of doses minus the number of fitted para-
meters at a 95% confidence level. Assessment of the
statistical significance of improvement of fit that a
two parameter model would provide over a single
parameter model was made by comparing the reduc-
tion in minimized deviance with the critical c
2 value
at 1 degree of freedom. Confidence intervals for the
best-fit model were estimated via bootstrapping [11].
Pooling analysis was performed for the different ani-
mals and bacterial species to ascertain whether the
data set had the same underlying distributions. A like-
lihood ratio test was used to determine if data could
be pooled.
Time post inoculation analysis
In the experiment conducted by Crist and co-investiga-
tors with BALB/c mice inoculated subcutaneously with
R. typhi, the responses were also recorded at different
post inoculation times [10]. Huang and Haas (2009)
developed dose-response models incorporating time
post inoculation as an additional parameter [13]. In
the exponential model, the k parameter is the probabil-
ity that a single organism can survive and proliferate in
order to initiate a response. It is well known that this
is a time-dependent process, and phenomenological
responses of animals to bacteria vary not only with the
initial dose of microorganisms, but also with the time
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Pathogen/
strain
Study/
Reference
Mode of
inoculation
Test animal/Response
Organism/Reponses end
point
Dose Number of Test
Animals
Positive
Responses
Negative
Responses
R. typhi
(Wilmington)
[10] s.c. BALB/c mice
(sero-conversion on day 9)
0.01(PFU) 10 0 10
0.1 10 0 10
11 0 0 1 0
10 10 0 10
100 10 0 10
1000 10 0 10
10000 10 10 0
R. typhi
(Wilmington)
[10] s.c. BALB/c mice
(sero-conversion on day
12)
0.01(PFU) 10 0 10
0.1 10 0 10
11 0 0 1 0
10 10 0 10
100 10 7 3
1000 10 8 2
10000 10 10 0
R. typhi
(Wilmington)
[10] s.c. BALB/c mice
(sero-conversion on day
15)
0.01(PFU) 10 0 10
0.1 10 0 10
11 0 1 9
10 10 5 5
100 10 9 1
1000 10 9 1
10000 10 10 0
R. typhi
(Wilmington)
[10] s.c. BALB/c mice
(sero-conversion on day
21)
0.01(PFU) 10 0 10
0.1 10 0 10
11 0 5 5
10 10 8 2
100 10 9 1
1000 10 10 0
10000 10 10 0
R. typhi
(Wilmington)
[10] s.c. BALB/c mice
(sero-conversion on day
28)
0.01(PFU) 10 0 10
0.1 10 3 7
11 0 8 2
10 10 9 1
100 10 10 0
1000 10 10 0
10000 10 10 0
R. typhi
(Ethiopian)
[8] i.d. Adult rat
(sero-conversion)
0.0435
(PFU)
50 5
0.435 5 1 4
4.35 5 5 0
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Page 3 of 14post inoculation (TPI). In the Beta-Poisson model, the
N50 parameter is the dose required to produce a
response in 50% of the exposed subjects. Directly
related to the growth kinetics of a single organism, the
initial dose to elicit response in 50% of the population
(N50) is also expected to vary with the time when the
response is observed. To model these effects, Huang et
al. [14,15] set the parameter k and N50 equal to func-
tions of time.
Results
Dose response model for Rickettsia typhi (Murine Typhus)
Dose-response model of adult rat exposed intradermally to
R. typhi, seroconversion as end point of response
Aringo-Jaramillo et al. (1984) studied an experimental
infection with Rickettsia typhi and antibody response
of adult and newborn laboratory rats. The best-fit dose
response model for seroconversion in intradermally
exposed adult rat was the exponential model. The
minimized deviance of the exponential model was 0.88,
which was well within the chi-square value at 7
degrees of freedom (i.e. 14.06). The statistics of the
two model fits to the animal are summarized in Table
2 and the best-fit model with confidence interval is
shown Figure 1.
Dose-response model of newborn rats exposed
subcutaneously to R. typhi, seroconversion as the end point
of response
T h eb e s t - f i td o s er e s p o n s em odel demonstrating ser-
oconversion in subcutaneously exposed newborn rats
was the exponential model. The difference in
deviances of the Beta-Poisson and the exponential
model was zero. Statistics of the two model fits to
the animal are summarized in Table 3 and the best-
fit model with confidence intervals shown is in Figure
2.
Table 1 Data Used (Continued)
43.5 5 5 0
435 5 5 0
4350 5 5 0
43500 5 5 0
R. typhi
(Ethiopian)
[8] i.d. Newborn rat
(sero-conversion)
0.0435
(PFU)
80 8
0.435 8 2 6
4.35 8 8 0
43.5 8 8 0
435 8 8 0
4350 8 8 0
R. typhi
(Ethiopian)
[9] Oral Young rat
3 day old
(sero-conversion)
10(PFU) 3 1 2
100 6 4 2
1000 3 3 0
10000 3 2 1
100000 5 5 0
R. typhi
(Ethiopian)
[9] Oral Young rat
7 day old
(sero-conversion)
10(PFU) 3 1 2
100 3 2 1
1000 2 2 0
10000 3 2 1
100000 3 3 0
R. typhi
(Ethiopian)
[9] Oral Young rat
30 day old
(sero-conversion)
10(PFU) 3 0 3
100 6 1 5
1000 3 2 1
10000 3 2 1
100000 3 2 1
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inoculated orally to R. typhi, seroconversion as end point
of response
Aringo-Jaramillo et al. (1988) conducted experimental
inoculation of R. typhi in young rats of different age
groups to study the influence of R. typhi in maternal
rats has on the offspring. Five different doses were
inoculated orally in 3-day, 7-day and 30-day old rats
and seroconversion was recorded as the end point of
response.
Dose-response model of young rat (3-days old) exposed
orally to R. typhi, seroconversion as the end point of
response
The best fit dose response model for seroconversion in
orally exposed young rats (3 day old) was the Beta-Pois-
son model. The minimized deviance of the exponential
model exceeded the chi-square value at 5 degrees of
freedom, but that of the Beta-Poisson model was well
within the critical chi-square value. Statistics of the two
model fits to the animal data are summarized in Table 4
and the best-fit model with confidence intervals is
shown in Figure 3.
Dose-response model of young rat (7 day old) exposed
orally to R. typhi, seroconversion as the end point of
response
The best-fit dose response model for seroconversion in
orally exposed young rats (7 days old) was the Beta-
Poisson model. Statistics of the two model fits to the
data are summarized in Table 5 and the best-fit model
with confidence intervals is shown in Figure 4.
Dose-response model of young rat (30 days old) exposed
orally to R. typhi, seroconversion as the end point of
response
The best fit dose response model for seroconversion in
orally exposed young rats (30 days old) was the Beta-
Poisson model. Statistics of the two model fits to the
animal are summarized in Table 6 and the best fit
model with confidence intervals is shown in Figure 5.
Figure 1 Dose Response Data and Exponential Model Fits for Seroconversion in Intradermally Exposed Adult rat to R. typhi and
Bootstrapped Exponential parameters.
Table 2 Model Fit Comparison for Seroconversion in Intradermally inoculated adult rats
Data
set
Number of
Doses
Model Minimized
Deviance
Degrees of
Freedom
ca,n-
k
2
Parameters Difference in
deviances
c
2 Value at 1 degree of
freedom
[8] 8 Exponential* 0.88 7 14.06 k = 0.756 0 3.84
8 Beta
Poisson
0.88 6 12.59 a =
01.16e8
N50 = 0.91
*Best fit model
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of BALB/c mice exposed subcutaneously to R. typhi,
seroconversion as the end point of response
Crist et al. (1984) experimented with R. typhi (R. moo-
seri) infection in normal and immune mice to study the
immune mechanism. Seroconversion after 12, 15, 21,
and 28 days of inoculation was best fit to the Beta-Pois-
son models. Seroconversion after 9 days had only two
responses and day zero to day 6 had no response at all.
In all models, the minimized deviances were well within
the chi-square distribution value at five degrees of free-
dom. Statistics of the two model fits to the animal test
data are summarized in Table 7 and the best fit model
with confidence intervals is shown in Figures 6, 7, 8 and
9.
Time-dose-response model for Murine Typhus in BALB/c
mice
Huang et al. (Huang, Bartrand et al. 2009; Huang and
Haas 2009) proposed a class of time-dose-response
models by incorporating the time post inoculation into
the classical dose-response models for microbial
infection. The parameter k in the exponential dose-
response model and the parameter N50 in the Beta-Pois-
son model were set equal to functions of time, which
presumably model the in vivo bacterial kinetics for a
single microorganism.
The proposed exponential and Beta-Poisson time-
dose-response models from these prior studies can be
given as:
The exponential and Beta-Poisson model with expo-
nential-reciprocal time dependency-
P(d,TPI) =1− e−e(k0 /TPI+k1) d (3)
where the parameter dependency is given by:
P(d,TPI) =1−
⎡
⎣1+
d
e
(j0/TPI+j1 ) ×
⎛
⎝2
1
α − 1
⎞
⎠
⎤
⎦
−α
P(d,TPI) =1−
⎡
⎣1+
d
e
(j0/TPI+j1 ) ×
⎛
⎝2
1
α − 1
⎞
⎠
⎤
⎦
−α
(4)
Figure 2 Dose Response Data and Exponential Model Fits for Seroconversion in Subcutaneously Exposed Newborn rat to R. typhi and
Bootstrapped Exponential parameters.
Table 3 Model Fit Comparison for Seroconversion in Subcutaneously Exposed Newborn rats
Data
set
Number of
Doses
Model Minimized
Deviance
Degrees of
Freedom
ca,n-
k
2
Parameters Difference in
deviances
c
2 Value at 1 degree of
freedom
[8] 7 Exponential* 1.12 6 12.59 k = 0.831 0 3.84
7 Beta
Poisson
1.12 5 11.07 a = 4.2e7
N50 = 0.83
*Best fit model
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Page 6 of 14where parameter dependency is given by
g(TPI) = e(j0/TPI+j1) The exponential and Beta-Poisson
models with power time dependency-
P(d,TPI) =1− e−e(k0/(TPI)k2 +k1) d (5)
where parameter dependency is given by
P(d,TPI) =1−
⎡
⎣1+
d
e
(j0/(TPI)j2+j1) ×
⎛
⎝2
1
α − 1
⎞
⎠
⎤
⎦
−α
P(d,TPI) =1−
⎡
⎣1+
d
e
(j0/(TPI)j2+j1) ×
⎛
⎝2
1
α − 1
⎞
⎠
⎤
⎦
−α
(6)
where parameter dependency is given by
g(TPI) = e(j0/(TPI)j2+j1)
The models with candidate time dependencies [13]
were fit to the data of the time-dependent antibody
response of mice after subcutaneous inoculation of
increasing doses of live R. typhi to study the time and
dose dependence of the antibody response. The
Figure 3 Dose Response Data and Beta-Poisson Model Fits for Seroconversion in Oral Exposed Young rat (3 day old) to R. typhi and
Bootstrapped Beta-Poisson Parameters.
Table 4 Model Fit Comparison for Seroconversion in Oral Exposed Young rat (3 days old)
Data
set
Number of
Doses
Model Minimized
Deviance
Degrees of
Freedom
ca,n-
k
2
Parameters Difference in
deviances
c
2 Value at 1 degree of
freedom
[9] 5 Exponential 34.63 4 11.07 k = 0.0006 31.60 3.84
5 Beta
Poisson*
3.023 3 9.48 a = 0.286
N50 = 25.7
*Best fit model
Table 5 Model Fit Comparison for Seroconversion in Oral Exposed Young rat (7 day old)
Data
set
Number of
Doses
Model Minimized
Deviance
Degrees of
Freedom
ca,n-
k
2
Parameters Difference in
deviances
c
2 Value at 1 degree of
freedom
[9] 5 Exponential 66.172 4 11.07 k = 0.0149 63.83 3.84
5 Beta
Poisson*
2.34 3 9.48 a = 0.241
N50 = 28.92
*Best fit model
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Page 7 of 14Figure 4 Dose Response Data and Beta-Poisson Model Fits for Seroconversion in Oral Exposed Young rat (7 day old) to R. typhi and
Bootstrapped Beta-Poisson parameters.
Table 6 Model Fit Comparison for Seroconversion in Oral Exposed Young rat (30 day old)
Data
set
Number of
Doses
Model Minimized
Deviance
Degrees of
Freedom
ca,n-
k
2
Parameters Difference in
deviances
c
2 Value at 1 degree of
freedom
[9] 5 Exponential 20.55 4 11.07 K = 4.2e-5 19.55 3.84
5 Beta
Poisson*
1.0 3 9.48 a = 0.20
N50 = 16.17
*Best fit model
Figure 5 Dose Response Data and Beta-Poisson Model Fits for Seroconversion in Oral Exposed Young rat (30 day old) to R. typhi and
Bootstrapped Beta-Poisson parameters.
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Page 8 of 14Table 7 Best fit model for seroconversion on different days after inoculation in subcutaneously exposed BALB/c mice
Data Number of Doses Model Minimized Deviance Degrees of Freedom ca,n-k
2 Parameters
Seroconversion after day 12 7 Beta Poisson* 4.19 5 11.07 a = 0.79
N50 = 94.80
Seroconversion after day 15 7 Beta Poisson* 1.40 5 11.07 a = 0.57
N50 = 10.46
Seroconversion after day 21 7 Beta Poisson* 2.77 5 11.07 a = 0.60
N50 = 1.67
Seroconversion after day 28 7 Beta Poisson* 1.59 5 11.07 a = 0.72
N50 = 0.28
*Best fit model
Figure 6 Dose Response Data and Beta-Poisson Model Fits for Seroconversion (12 days after inoculation) in Subcutaneously Exposed
BALB/c mice to R. typhi and Bootstrapped Beta-Poisson parameters.
Figure 7 Dose Response Data and Beta-Poisson Model Fits for Seroconversion (15 days after inoculation) in Subcutaneously Exposed
BALB/c mice to R. typhi and Bootstrapped Beta-Poisson parameters.
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and (6) were 109.24, 26.98, 104.66 and 26.47 respec-
tively. The two-parameter modified Beta-Poisson model
based on equation (4) provided the best (and statistically
acceptable) fit to the data. The best-fit model was then
plotted to compare visually with the antibody response
in Figure 10. It can be seen that the model is closely
aligned with the data.
Pooling analysis
Pooling analysis was performed to ascertain whether dif-
ferent data sets could be described by a single dose-
response relationship. Different combinations of species,
strains, routes of infection and hosts were pooled
together and a likelihood ratio test was used to deter-
mine whether the data could be pooled or not.
Figure 8 Dose Response Data and Beta-Poisson Model Fits for Seroconversion (21 days after inoculation) in Subcutaneously Exposed
BALB/c mice to R. typhi and Bootstrapped Beta-Poisson parameters.
Figure 9 Dose Response Data and Beta-Poisson Model Fits for Seroconversion (28 days after inoculation) in Subcutaneously Exposed
BALB/c mice to R. typhi and Bootstrapped Beta-Poisson parameters.
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neously inoculated newborn rats with R. typhi (Ethio-
pian strain) could be pooled. The difference in
deviances between the sum of individual best fits and
the pooled model’sb e s tf i tw a sz e r ow h i c hw a sl e s s
thanthe c2 0.05,1 value (3.841). The summary and statis-
tics of the pooling analysis are shown in Table 8 and
the best fit model is shown in Figure 11.
Similarly, young rats of different age groups were
orally exposed to graded doses of R. typhi orally. All the
data could be pooled irrespective of the age of the ani-
mals. The value of the difference in deviances between
sum of individual best fits and pooled best fit was 0.01
which was less than c2 0.05,1 value (3.841). Statistics of
the pooled data are summarized in Table 9 and best fit
model of the pooled data is shown in Figure 12.
Discussion
Aringo-Jaramillo et al. (1984) studied the antibody
response of adult and newborn laboratory rats exposing
them intradermally and subcutaneously with R. typhi.
Both newborn (3 day old) and adult rats were highly
susceptible to R. typhi inoculated either subcutaneously
or intradermally. The ID50 for adult rat was 0.91 PFU
and for newborn rat was 0.88 PFU. Both routes of infec-
tion are considered natural mode of infection analogues
to a flea bite[16]. The exponential model provided the
best fit in both cases, indicating that the responses were
homogenous in the population, and the routes of infec-
tion were interchangeable statistically. Moreover, the
data could be pooled and as shown in Figure 11, the
best fit lines of each of the individual models and the
pooled model overlapped one another indicating that
responses in rats are independent of the age factor and
mode of inoculation (intradermal and subcutaneous).
The comparative table as shown in Table 10 also shows
there are no significant differences in ID50,I D 10 and
ID01.
Similarly, Aringo-Jaramillo et al. (1988) studied the
influence of maternal R. typhi in young rats of different
Figure 10 Time-Dependent Model for Antibody Response of BALB/c mice after subcutaneous inoculation of increasing doses of live R.
mooseri.
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Page 11 of 14age groups inoculating R. typhi orally. All data for every
age of rat (3 day-old, 7 day-old and 30 day-old) could
be pooled and represented by a best fit Beta-Poisson
model. Scattered points at right of the graphs (Figure 6,
7 and 8) are high alpha values and those points tend to
fit exponential model while majority 99.9% were at
dense cluster. The result indicates that the rats inocu-
lated orally show homogeneity in response and a single
dose-response relationship could describe all the age
groups. There are no significant differences in ID50so f
individual age groups but the median infective value is
significantly higher than rats inoculated intradermally or
subcutaneously. The reason behind the higher ID50 may
be the route of inoculation. The number of pathogens
that reach endothelial cells via the oral route might sig-
nificantly be less than the initial inoculation.
Crist et al. (1984) recorded post time inoculation
responses while inoculating R. typhi (R. mooseri) to
BALB/c mice. In days 0-6, there was no response. There
was only one response at the highest dose on day 9.
From day 12 to 28, there were systemic responses to
corresponding doses. The data of seroconversion of
BALB/c mice after days 12, 15, 21 and 28 were best fit
to a Beta-Poisson model. The post inoculation effect
Table 8 Adult rat and Newborn rat Pooled Data
Data Number of Doses Best fit Model Minimized Deviance Degrees of Freedom ca,n-k
2 Parameters
Adult rat exposed intradermally 8 Exponential 0.88 7 14.06 K = 0.756
Newborn rat exposed subcutaneously 7 Exponential 1.12 6 12.59 K = 0.831
Pooled data 15 Exponential 2.0 14 23.68 K = 0.801
Figure 11 Best fit model of Adult rat, newborn rat and pooled data.
Table 9 Young rat of different ages Pooled Data
Data Number of Doses Best fit Model Minimized Deviance Degrees of Freedom ca,n-k
2 Parameters
Young rat 3-day old 5 Beta-Poisson 3.023 3 7.81 a = 0.286
N50 = 25.7
Young rat 7-day old 5 Beta-Poisson 2.34 3 7.81 a = 0.241
N50 = 28.92
Young rat 30-day old 5 Beta-Poisson 1.0 3 7.81 a = 0.20
N50 = 16.17
Pooled data 15 Beta-Poisson 13.53 13 22.36 a = 0.213
N50 = 106.14
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Page 12 of 14was analyzed with the data set using a time post inocu-
lation model as described in prior work [13,14]. Figure
10 shows the different dose-response curves for different
time (days) after inoculation.
Conclusion
Human murine typhus caused by Rickettsia typhi (R.
mooseri) is an infectious disease that requires the fewest
number of pathogens to initiate disease. The dose-
response models developed in this study support this
effect. Intradermally or subcutaneously inoculated rats
(adult and newborn) dose response models suggest that
less than 1 PFU (ranging between 0.38 and 1.33 PFU as
estimated within the models’ 95% confidence limits) of
the pathogen is enough to seroconvert 50% of the
exposed population o average. The BALB/c mouse time
post inoculation model also indicates that an average
dose of 0.28 PFU (0.75 to 0.11 PFU within a 95% confi-
dence interval) will cause seroconversion in of 50% of
the exposed population with a mean time to effect of 28
days. The difference in median infectious dose (serocon-
version) in adult rat and BALB/c mice is not a signifi-
cant one and it may be because of the different strains
of pathogen used to infect the test subjects. The model
suggests that the higher the number of pathogens, the
sooner the seroconversion. Pooling analysis of adult and
newborn rats shows that there is no significant effect
due to different routes of inoculation and can be
described by the same dose-response relationship. Simi-
larly, pooling of orally inoculated young rats of different
age groups indicates that there is no significant effect of
age in serocenversion. However, there is an observed
variation in response related to age groups seen in
human case studies. According to Al-Awadi et al.,t h e
most susceptible age group was the 15-25 years, fol-
lowed by the 26 to 44 year age group. But there is no
definite pattern of variation [17,18]. This is also the first
study to incorporate time in a dose-response model for
murine typhus. The outcome may improve current
understanding of in vivo bacterial dynamics, post-
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Figure 12 Best fit models of Young rat (different age group) and pooled data.
Table 10 Comparative values of ID50, ID10 and ID01
Pathogen Host Route ID01 ID10 ID50
R. mooseri Newborn rat sc 0.012 0.12 0.83
Adult rat id 0.013 0.14 0.91
Pooled data 0.012 0.13 0.86
sc = subcutaneous
id = intradermal
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Page 13 of 14exposure decision-making or as a component to assist
epidemiological investigations.
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